|
|
||||||||
1 From the Department of Experimental Ophthalmology, University Eye Hospital, Tübingen, Germany; the 2 Department of Medical Biometry, University of Tübingen, Germany; and the 3 Institute of Human Genetics, Biocenter, University of Würzburg, Germany.
PURPOSE. To study the dynamics of the long (L)- and middle (M)-wavelengthsensitive cone-driven pathways and their interactions in patients with Stargardts macular dystrophy-fundus flavimaculatus (SMD-FF) and to correlate them with other clinical parameters and individual genotypes.
METHODS. Forty-seven patients with SMD-FF participated in the study. In addition to standard 30-Hz flicker electroretinograms (30-Hz fERG), ERG responses were measured to stimuli that modulated exclusively the L or the M cones (L/M cones) or the two simultaneously. Blood samples were screened for mutations in the 50 exons of the ABCA4 gene.
RESULTS. Patients with SMD-FF did not show a decrease in the mean L/M-conedriven ERG sensitivity, but there was a significant increase in the interindividual variability. The mean L-/M-cone weighting ratio was normal. However, the L-conedriven ERG was significantly phase delayed, whereas the M-conedriven ERG was significantly phase advanced. These phase changes were significantly correlated with disease duration. The amplitude and implicit time of the standard 30-Hz fERG both correlated significantly with the L/M-conedriven ERG sensitivity and with the phase difference between the L/M-conedriven ERGs, indicating the complex origin of the standard 30-Hz fERG. Probable disease-associated mutations in the ABCA4 gene were found in 40 of 45 patients, suggesting that they form a genetically fairly uniform SMD-FF study group. There was no correlation between the genotype and the L/M-conedriven ERGs.
CONCLUSIONS. The changes in L/M-conedriven ERG sensitivity and phase possibly represent two independent disease processes. The phase changes are similar to those found in patients with retinitis pigmentosa and possibly are a general feature of retinal dystrophies.
This article has been cited by other articles:
![]() |
S. Maia-Lopes, E. D. Silva, M. F. Silva, A. Reis, P. Faria, and M. Castelo-Branco Evidence of Widespread Retinal Dysfunction in Patients with Stargardt Disease and Morphologically Unaffected Carrier Relatives Invest. Ophthalmol. Vis. Sci., March 1, 2008; 49(3): 1191 - 1199. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Vasireddy, M. M. Jablonski, M. N. A. Mandal, D. Raz-Prag, X. F. Wang, L. Nizol, A. Iannaccone, D. C. Musch, R. A. Bush, N. Salem Jr, et al. Elovl4 5-bp-Deletion Knock-in Mice Develop Progressive Photoreceptor Degeneration. Invest. Ophthalmol. Vis. Sci., October 1, 2006; 47(10): 4558 - 4568. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. P. N. Scholl, D. Besch, R. Vonthein, B. H. F. Weber, and E. Apfelstedt-Sylla Alterations of Slow and Fast Rod ERG Signals in Patients with Molecularly Confirmed Stargardt Disease Type 1 Invest. Ophthalmol. Vis. Sci., April 1, 2002; 43(4): 1248 - 1256. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |